Kodiak Sciences, Inc. (KOD)
43.11
+0.75
(+1.77%)
USD |
NASDAQ |
Apr 10, 16:00
43.04
-0.06
(-0.15%)
After-Hours: 20:00
Kodiak Sciences Shareholders Equity (Quarterly) : 157.38M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Tango Therapeutics, Inc. | 346.18M |
| Eli Lilly & Co. | 26.54B |
| Catalyst Pharmaceuticals, Inc. | 954.27M |
| Madrigal Pharmaceuticals, Inc. | 602.69M |
| ADMA Biologics, Inc. | 477.32M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 351.53M |
| Total Liabilities (Quarterly) | 194.15M |
| Debt to Equity Ratio | 1.011 |
| Current Ratio | 4.718 |
| Net Debt Paydown Yield | 0.17% |